Targeting neuroinflammation in Alzheimer’s disease

References

• StefaniakJO’BrienJImaging of neuroinflammation in dementia: a reviewJ Neurol Neurosurg Psychiatry2016871212826384512
   PubMed Web of Science ®Google Scholar
• PrinceMWimoAGuerchetMAliGCWuYTPrinaMWorld Alzheimer Report 2015. The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and TrendsAlzheimer’s Disease International2015
   Google Scholar
• AlzheimerAUber eine eigenartige Erkangkung der Hirnrinde (An unusual illness of the cerebral cortex)Allgemeine Zeitschr Psychisch-Gerichtliche Medizin190764146148
   Google Scholar
• SperlingRAAisenPSBeckettLAToward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s diseaseAlzheimers Dement2011728029221514248
   PubMed Web of Science ®Google Scholar
• LopezOLSchwamECummingsJPredicting cognitive decline in Alzheimer’s disease: an integrated analysisAlzheimers Dement2010643143921044773
   PubMed Web of Science ®Google Scholar
• QuerfurthHWLaFerlaFMAlzheimer’s diseaseN Engl J Med2010362432934420107219
   PubMed Web of Science ®Google Scholar
• BraakHBraakEMorphological criteria for the recognition of Alzheimer’s disease and the distribution pattern of cortical changes related to this disorderNeurobiol Aging1994355356 discussion 379–3807936061
   PubMed Web of Science ®Google Scholar
• BlennowKde LeonMJZetterbergHAlzheimer’s diseaseLancet200636838740316876668
   PubMed Web of Science ®Google Scholar
• FerreiraSTClarkeJRBomfimTRDe FeliceFGInflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer’s diseaseAlzheimers Dement2014101 SupplS76S8324529528
   PubMed Web of Science ®Google Scholar
• BrownKLCosseauCGardyJLHancockREComplexities of targeting innate immunity to treat infectionTrends Immunol20072826026617468048
   PubMed Web of Science ®Google Scholar
• ProkopSMillerKRHeppnerFLMicroglia actions in Alzheimer’s diseaseActa Neuropathol201312646147724224195
   PubMedGoogle Scholar
• PerryVHHolmesCMicroglial priming in neurodegenerative diseaseNature Rev Neurol20141021722424638131
   PubMed Web of Science ®Google Scholar
• HenekaMTKummerMPLatzEInnate immune activation in neurodegenerative diseaseNature Rev Immunol20141446347724962261
   PubMed Web of Science ®Google Scholar
• ZhangBGaiteriCBodeaLGIntegrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s diseaseCell201315370772023622250
   PubMed Web of Science ®Google Scholar
• ShengJGBoraSHXuGBorcheltDRPriceDLKoliatsosVELipopolysaccharide induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic miceNeurobiol Dis20031413314513678674
   PubMed Web of Science ®Google Scholar
• KitazawaMOddoSYamasakiTRLipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer’s diseaseJ Neurosci2005258843885316192374
   PubMed Web of Science ®Google Scholar
• VukicVCallaghanDWalkerDExpression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer’s brain is mediated by the JNK-AP1 signaling pathwayNeurobiol Dis2009349510619162185
   PubMed Web of Science ®Google Scholar
• CunninghamCCampionSLunnonKSystemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative diseaseBiol Psychiatry20096530431218801476
   PubMed Web of Science ®Google Scholar
• VezzaniMMarosoMBalossoSSanchezMABartfaiTIL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizuresBrain Behav Immun20112571281128921473909
   PubMed Web of Science ®Google Scholar
• VerkhratskyARodríguezJJSteardoLAstrogliopathology: a central element of neuropsychiatric diseases?Neuroscientist201420657658824301046
   PubMed Web of Science ®Google Scholar
• SteardoLJrBronzuoliMRIacominoAEspositoGSteardoLScuderiCDoes neuroinflammation turn on the flame in Alzheimer’s disease? Focus on astrocytesFront Neurosci2015925926283900
   PubMed Web of Science ®Google Scholar
• LécuyerMAKebirHPratAGlial influences on BBB functions and molecular players in immune cell traffickingBiochim Biophys Acta20161862347248226454208
   PubMed Web of Science ®Google Scholar
• EspositoGScuderiCLuJS100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cellsJ Cell Mol Med200812391492718494933
   PubMed Web of Science ®Google Scholar
• VerkhratskyANedergaardMHertzLWhy are astrocytes important?Neurochem Res201540238940125113122
   PubMed Web of Science ®Google Scholar
• DeitmerJWRoseCRpH regulation and proton signalling by glial cellsProg Neurobiol1996482731038737439
   PubMed Web of Science ®Google Scholar
• IadecolaCNedergaardMGlial regulation of the cerebral microvasculatureNat Neurosci200710111369137617965657
   PubMed Web of Science ®Google Scholar
• ZlokovicBVThe blood-brain barrier in health and chronic neurodegenerative disordersNeuron200857217820118215617
   PubMed Web of Science ®Google Scholar
• PereaGNavarreteMAraqueATripartite synapses: astrocytes process and control synaptic informationTrends Neurosci200932842143119615761
   PubMed Web of Science ®Google Scholar
• SofroniewMVAstrogliosis: Diversity of astrocyte functions and phenotypes in neural circuitsCold Spring Harb Perspect Biol201472a02042025380660
   PubMed Web of Science ®Google Scholar
• SofroniewMVVintersHVAstrocytes: biology and pathologyActa Neuropathol2010119173520012068
   PubMed Web of Science ®Google Scholar
• ScuderiCSteccaCIacominoASteardoLRole of astrocytes in major neurological disorders: the evidence and implicationsIUBMB Life2013651295796124376207
   PubMed Web of Science ®Google Scholar
• ParadisiSSacchettiBBalduzziMGaudiSMalchiodi-AlbediFAstrocyte modulation of in vitro beta-amyloid neurotoxicityGlia200446325226015048848
   PubMed Web of Science ®Google Scholar
• ThalDRThe role of astrocytes in amyloid beta-protein toxicity and clearanceExp Neurol20122361522575598
   PubMed Web of Science ®Google Scholar
• MathurRIncePGMinettTA reduced astrocyte response to β-amyloid plaques in the ageing brain associates with cognitive impairmentPLoS One2015102e011846325707004
   PubMed Web of Science ®Google Scholar
• MrakREGriffinWSThe role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer’s diseaseNeurobiol Aging200122691592211754999
   PubMed Web of Science ®Google Scholar
• TuppoEEAriasHRThe role of inflammation in Alzheimer’s diseaseInt J Biochem Cell Biol200537228930515474976
   PubMed Web of Science ®Google Scholar
• FrautschySAYangFIrrizarryMMicroglial response to amyloid plaques in APPsw transgenic miceAm J Pathol19981523073179422548
   PubMed Web of Science ®Google Scholar
• LiuBHongJSRole of Microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic interventionJ Pharm Exp Ther200330417
   PubMed Web of Science ®Google Scholar
• MelchiorBGarciaAEHsiungBKDual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer’s diseaseASN Neuro201023e0003720640189
   PubMed Web of Science ®Google Scholar
• JiangTTanLZhuXCUpregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer’s diseaseNeuropsychopharmacol2014391329492962
   PubMed Web of Science ®Google Scholar
• GuerreiroRWojtasABrasJTREM2 variants in Alzheimer’s diseaseN Engl J Med201336811712723150934
   PubMed Web of Science ®Google Scholar
• JonssonTStefanssonHSteinbergSVariant of TREM2 associated with the risk of Alzheimer’s diseaseN Engl J Med201336810711623150908
   PubMed Web of Science ®Google Scholar
• TakahashiKRochfordCDNeumannHClearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2J Exp Med200520164765715728241
   PubMed Web of Science ®Google Scholar
• OteroKShinoharaMZhaoHTREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesisJ Immunol201218862612262122312126
   PubMed Web of Science ®Google Scholar
• BouchonAHernandez-MunainCCellaMColonnaMADAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cellsJ Exp Med20011941111112211602640
   PubMed Web of Science ®Google Scholar
• Wyss-CorayTLoikeJDBrionneTCAdult mouse astrocytes degrade amyloid-beta in vitro and in situNat Med2003945345712612547
   PubMed Web of Science ®Google Scholar
• Rubio-PerezJMMorillas-RuizJMA review: inflammatory process in Alzheimer’s disease, role of cytokinesScientific World J20122012756357
   Web of Science ®Google Scholar
• TownTNikolicVTanJThe microglial “activation” continuum: from innate to adaptive responsesJ Neuroinflammation200522416259628
   PubMed Web of Science ®Google Scholar
• GandySHeppnerFLMicroglia as dynamic and essential components of the amyloid hypothesisNeuron20137857557723719156
   PubMed Web of Science ®Google Scholar
• SudduthTLSchmittFANelsonPTWilcockDMNeuroinflammatory phenotype in early Alzheimer’s diseaseNeurobiol Aging2013341051105923062700
   PubMed Web of Science ®Google Scholar
• HolmesCCunninghamCZotovaESystemic inflammation and disease progression in Alzheimer diseaseNeurology20097376877419738171
   PubMed Web of Science ®Google Scholar
• ScuderiCSteccaCValenzaMPalmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s diseaseCell Death Dis20145e141925210802
   PubMed Web of Science ®Google Scholar
• BlockMLHongJSMicroglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanismProg Neurobiol200576779816081203
   PubMed Web of Science ®Google Scholar
• ChristovAOttmanJTGrammasPVascular inflammatory, oxidative and protease-based processes: implications for neuronal cell death in Alzheimer’s diseaseNeurol Res200426554054615265271
   PubMed Web of Science ®Google Scholar
• LiuXWuZHayashiYNakanishiHAge-dependent neuroinflammatory responses and deficits in long-term potentiation in the hippocampus during systemic inflammationNeuroscience201221613314222554776
   PubMed Web of Science ®Google Scholar
• OlabarriaMNoristaniHNVerkhratskyARodríguezJJConcomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer’s diseaseGlia201058783183820140958
   PubMed Web of Science ®Google Scholar
• BargerSWHarmonADMicroglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein ENature199738866458788819278049
   PubMed Web of Science ®Google Scholar
• YuYYeRDMicroglial Aβ receptors in Alzheimer’s diseaseCell Mol Neurobiol2015351718325149075
   PubMed Web of Science ®Google Scholar
• CaiZLiuNWangCRole of RAGE in Alzheimer’s DiseaseCell Mol Neurobiol201636448349526175217
   PubMed Web of Science ®Google Scholar
• LeYGongWTiffanyHLAmyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1J Neurosci2001212RC12311160457
   PubMed Web of Science ®Google Scholar
• PengLYuYLiuJThe chemerin receptor CMKLR1 is a functional receptor for amyloid-beta peptideJ Alzheimers Dis2014431227242
   Web of Science ®Google Scholar
• StewartCRStuartLMWilkinsonKCD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimerNature Immunol20101115516120037584
   PubMed Web of Science ®Google Scholar
• KoenigsknechtJLandrethGMicroglial phagocytosis of fibrillar β-amyloid through a β1 integrin-dependent mechanismJ Neurosci2004498389846
   Web of Science ®Google Scholar
• von BernhardiRTichauerJEEugenínJAging dependent changes of microglial cells and their relevance for neurodegenerative disordersJ Neurochem20101121099111420002526
   PubMed Web of Science ®Google Scholar
• LiKLiuSYaoSWangBDaiDYaoLInteraction between interleukin-8 and methylenetetrahydrofolate reductase genes modulates Alzheimer’s disease riskDement Geriatr Cogn Disord20092728629119246914
   PubMed Web of Science ®Google Scholar
• WestinKBuchhavePNielsenHMinthonLJanciauskieneSHanssonOCCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer’s diseasePLoS One20127e3052522303443
   PubMed Web of Science ®Google Scholar
• WuJBieBYangHXuJJBrownDLNaguibMSuppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiencyNeurobiol Aging2013342843285223855980
   PubMed Web of Science ®Google Scholar
• YuSLiuYPLiuYHDiagnostic utility of VEGF and soluble CD40L levels in serum of Alzheimer’s patientsYu Clin Chim Acta201645315415926706786
   PubMed Web of Science ®Google Scholar
• AlamQAlamMZMushtaqGInflammatory process in Alzheimer and Parkinson’s diseases: central role of cytokinesCurr Pharm Des201622554154826601965
   PubMed Web of Science ®Google Scholar
• ShenYMeriSYin and Yang: complement activation and regulation in Alzheimer’s diseaseProg Neurobiol200370646347214568360
   PubMed Web of Science ®Google Scholar
• WangWYTanMSYuJTTanLRole of pro-inflammatory cytokines released from microglia in Alzheimer’s diseaseAnn Transl Med201531013626207229
   PubMed Web of Science ®Google Scholar
• SierraAGottfried-BlackmoreACMcewenBSBullochKMicroglia derived from aging mice exhibit an altered inflammatory profileGlia20075541242417203473
   PubMed Web of Science ®Google Scholar
• Welser-AlvesJVMilnerRMicroglia are the major source of TNF-alpha and TGF-beta1 in post natal glial cultures; regulation by cytokines, lipopolysaccharide and vitronectinNeurochem Int201363475323619393
   PubMed Web of Science ®Google Scholar
• VarnumMMKiyotaTIngrahamKLIkezuSIkezuTThe anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer’s diseaseNeurobiol Aging201536112995300726315370
   PubMed Web of Science ®Google Scholar
• LyonsAMcQuillanKDeighanBDecreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharideBrain Behav Immunol200923710201027
   Web of Science ®Google Scholar
• WalkerDGDalsing-HernandezJECampbellNALueLFDecreased expression of CD200 and CD200 receptor in Alzheimer’s disease: a potential mechanism leading to chronic inflammationExp Neurol2009215151918938162
   PubMed Web of Science ®Google Scholar
• WuDZhangXZhaoMZhouALThe role of the TLR4/NF-κB signaling pathway in Aβ accumulation in primary hippocampal neuronsActa Physiologica Sinica201567331932826109305
   PubMedGoogle Scholar
• FeldMKrawczykMCSol FustiñanaMDecrease of ERK/MAPK overactivation in prefrontal cortex reverses early memory deficit in a mouse model of Alzheimer’s diseaseJ Alzheimers Dis2014401698224334722
   PubMed Web of Science ®Google Scholar
• SpriggsDRDeutschSKufeDWGenomic structure, induction and production of TNF-alphaImmunol Ser1992563341550865
   PubMedGoogle Scholar
• FeijooCCampbellDGJakesRGoedertMCuendaAEvidence that phosphorylation of the microtubule-associated protein Tau by SAPK4/p38delta at Thr50 promotes microtubule assemblyJ Cell Sci200511839740815632108
   PubMed Web of Science ®Google Scholar
• LiaoYFWangBJChengHTKuoLHWolfeMSTumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathwayJ Biol Chem20042794749523493215347683
   PubMed Web of Science ®Google Scholar
• ChenCHZhouWLiuSIncreased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer’s diseaseInt J Neuropsychopharmacol2012151779021329555
   PubMed Web of Science ®Google Scholar
• MunozLAmmitAJTargeting p38 MAPK pathway for the treatment of Alzheimer’s diseaseNeuropharmacology201058356156819951717
   PubMed Web of Science ®Google Scholar
• GlassCKSaijoKWinnerBMarchettoMCGageFHMechanisms underlying inflammation in neurodegenerationCell2010140691893420303880
   PubMed Web of Science ®Google Scholar
• LianHLitvinchukAChiangACAithmittiNJankowskyJLZhengHAstrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer’s diseaseJ Neurosci201636257758926758846
   PubMed Web of Science ®Google Scholar
• FattahiMJMirshafieyAPositive and negative effects of prostaglandins in Alzheimer’s diseasePsychiatry Clin Neurosci2014681506023992456
   PubMed Web of Science ®Google Scholar
• MalinskiTNitric oxide and nitroxidative stress in Alzheimer’s diseaseJ Alzheimers Dis20071120721817522445
   PubMed Web of Science ®Google Scholar
• HuJFerreiraAVan EldikLJS100β induces neuronal cell death through nitric oxide release from astrocytesJ Neurochem199769229423019375660
   PubMed Web of Science ®Google Scholar
• MoriT1KoyamaNArendashGWHorikoshi-SakurabaYTanJTownTOverexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer’s diseaseGlia201058330031419705461
   PubMed Web of Science ®Google Scholar
• ShepherdCEGoyetteJUtterVInflammatory S100A9 and S100A12 proteins in Alzheimer’s diseaseNeurobiol Aging200627111554156316253391
   PubMed Web of Science ®Google Scholar
• VoglTGharibyanALMorozova-RocheLAProinflammatory S100A8 and S100A9 proteins: self-assembly into multifunctional native and amyloid complexesInt J Mol Sci20121332893291722489132
   PubMed Web of Science ®Google Scholar
• WangCKlechikovAGGharibyanALThe role of pro-inflammatory S100A9 in Alzheimer’s disease amyloid-neuroinflammatory cascadeActa Neuropathol2014127450752224240735
   PubMed Web of Science ®Google Scholar
• CzapskiGAGąssowskaMWilkaniecAChalimoniukMStrosznajderJBAdamczykAThe mechanisms regulating cyclin-dependent kinase 5 in hippocampus during systemic inflammatory response: the effect on inflammatory gene expressionNeurochem Int20169310311226806339
   PubMed Web of Science ®Google Scholar
• QuintanillaRAOrellanaDGonzalez-BillaultCMaccioniRBInterleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathwayExp Cell Res2004295124525715051507
   PubMed Web of Science ®Google Scholar
• RosenbergerAFMorremaTHGerritsenWHIncreased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathologyJ Neuroinflammation2016131426732432
   PubMed Web of Science ®Google Scholar
• TerrandoNErikssonLIRyuJKResolving postoperative neuroinflammation and cognitive declineAnn Neurol201170698699522190370
   PubMed Web of Science ®Google Scholar
• EngelhardtBT cell migration into the central nervous system during health and disease: different molecular keys allow access to different central nervous system compartmentsClin Exp Neuroimmunol201017993
   Google Scholar
• WonDDorovini-ZisKVincentSRCytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood–brain barrierExp Neurol2004190244645515530883
   PubMed Web of Science ®Google Scholar
• DeaneRDu YanSSubmamaryanRKRAGE mediates amyloid-beta peptide transport across the blood–brain barrier and accumulation in brainNat Med20039790791312808450
   PubMed Web of Science ®Google Scholar
• JaegerLBDohguSSultanaRLipopolysaccharide alters the blood–brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer’s diseaseBrain Behav Immun200923450751719486646
   PubMed Web of Science ®Google Scholar
• LiuYPLinHITzengSFTumor necrosis factor-alpha and interleukin-18 modulate neuronal cell fate in embryonic neural progenitor cultureBrain Res20051054215215816054598
   PubMed Web of Science ®Google Scholar
• BernierPJBedardAVinetJLevesqueMParentANewly generated neurons in the amygdala and adjoining cortex of adult primatesProc Natl Acad Sci USA20029917114641146912177450
   PubMed Web of Science ®Google Scholar
• PhielCJWilsonCALeeVMKleinPSGSK-3alpha regulates production of Alzheimer’s disease amyloid-beta peptidesNature2003423693843543912761548
   PubMed Web of Science ®Google Scholar
• MartinMRehaniKJopeRSMichalekSMToll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3Nat Immunol20056877778416007092
   PubMed Web of Science ®Google Scholar
• WangMJHuangHYChenWFChangHFKuoJSGlycogen synthase kinase-3beta inactivation inhibits tumor necrosis factor-alpha production in microglia by modulating nuclear factor κB and MLK3/JNK signaling cascadesJ Neuroinflammation201079921194439
   PubMed Web of Science ®Google Scholar
• HuangWCLinYSWangCYGlycogen synthase kinase-3negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cellsImmunology20091281 SupplS275S286
   Web of Science ®Google Scholar
• CastelloMAJeppsonJDSorianoSMoving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer’s diseaseBMC Neurol20141416925179671
   PubMed Web of Science ®Google Scholar
• FrautschySAColeGMWhy pleiotropic interventions are needed for Alzheimer’s diseaseMol Neurobiol20104139240920437209
   PubMed Web of Science ®Google Scholar
• von BernhardiRCornejoFParadaGEEugenínJRole of TGFβ signaling in the pathogenesis of Alzheimer’s diseaseFront Cell Neurosci2015942626578886
   PubMed Web of Science ®Google Scholar
• KitazawaMChengDTsukamotoMRBlocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal β-catenin pathway function in an Alzheimer’s disease modelJ Immunol20111876539654922095718
   PubMed Web of Science ®Google Scholar
• ShiJQShenWChenJAnti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brainsBrain Res2011136823924720971085
   PubMed Web of Science ®Google Scholar
• HePChengXStaufenbielMLong-term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of β-secretase in a mouse model of Alzheimer’s diseasePLoS One201382e5509123405115
   PubMed Web of Science ®Google Scholar
• TweedieDFergusonRAFishmanKTumor necrosis factor-α synthesis inhibitor 3,6′-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer’s diseaseJ Neuroinflammation2012910622642825
   PubMed Web of Science ®Google Scholar
• GarwoodCJCooperJDHangerDPNobleWAntiinflammatory impact of minocycline in a mouse model of tauopathyFront Psychiatry2010113621423446
   PubMedGoogle Scholar
• ParachikovaAVasilevkoVCribbsDHLaFerlaFMGreenKNReductions in amyloid-beta-derived neuroinflammation, with minocycline, restore cognition but do not significantly affect tau hyperphosphorylationJ Alzheimers Dis201021252754220555131
   PubMed Web of Science ®Google Scholar
• ScuderiCSteccaCBronzuoliMRSirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s diseaseFront Pharmacol201458924860504
   PubMed Web of Science ®Google Scholar
• BiccaMACostaRLoch-NeckelGFigueiredoCPMedeirosRCalixtoJBB2 receptor blockage prevents Aβ-induced cognitive impairment by neuroinflammation inhibitionBehav Brain Res201527848249125446751
   PubMed Web of Science ®Google Scholar
• GanPZhangLChenYAnti-inflammatory effects of glaucocalyxin B in microglia cellsJ Pharmacol Sci20151281354626003084
   PubMed Web of Science ®Google Scholar
• ScuderiCSteardoLNeuroglial roots of neurodegenerative diseases: therapeutic potential of palmitoylethanolamide in models of Alzheimer’s diseaseCNS NeurolDisord Drug Targets20131216269
   Web of Science ®Google Scholar
• CirilloCCapocciaEIuvoneTS100B inhibitor pentamidine attenuates reactive gliosis and reduces neuronal loss in a mouse model of Alzheimer’s diseaseBiomed Res Int2015201550834226295040
   PubMed Web of Science ®Google Scholar
• GreenHFNolanYMGSK-3 mediates the release of IL-1β, TNF-α and IL-10 from cortical gliaNeurochem Int201261566667122796213
   PubMed Web of Science ®Google Scholar
• AndersenKLaunerLJOttAHoesAWBretelerMMHofmanADo nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer’s disease? The Rotterdam studyNeurology1995458144114457644037
   PubMed Web of Science ®Google Scholar
• GaspariniLOnginiEWenkGNon-steroidal antiinflammatory drugs (NSAIDs) in Alzheimer’s disease: old and new mechanisms of actionJ Neurochem200491352153615485484
   PubMed Web of Science ®Google Scholar
• FeldmanHHDoodyRSKivipeltoMRandomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADeNeurology2010741295696420200346
   PubMed Web of Science ®Google Scholar
• LyketsosCGBreitnerJCGreenRCNaproxen and celecoxib do not prevent AD in early results from a randomized controlled trialNeurology2007681800180817460158
   PubMed Web of Science ®Google Scholar
• MartinBKSzekelyCBrandtJCognitive function over time in the Alzheimer’s Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxibArch Neurol20086589690518474729
   PubMed Web of Science ®Google Scholar
• de JongDJansenRHoefnagelsWNo effect of one-year treatment with indomethacin on Alzheimer’s disease progression: a randomized controlled trialPLoS One200831e147518213383
   PubMed Web of Science ®Google Scholar
• ReinesSABlockGAMorrisJCRofecoxib: no effect on Alzheimer’s disease in a 1-year, randomized, blinded, controlled studyNeurology2004621667114718699
   PubMed Web of Science ®Google Scholar
• ThalLJFerrisSHKirbyLRofecoxib Protocol 078 study group. A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairmentNeuropsychopharmacol200530612041215
   PubMed Web of Science ®Google Scholar
• BreitnerJCBakerLDMontineTJExtended results of the Alzheimer’s disease anti-inflammatory prevention trialAlzheimers Dement20117440241121784351
   PubMed Web of Science ®Google Scholar
• BaumLLamCWCheungSKSix-month randomized, placebo controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer diseaseJ Clin Psychopharmacol200828111011318204357
   PubMed Web of Science ®Google Scholar
• ShintoLQuinnJMontineTA randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer’s diseaseJ Alzheimers Dis201438111112024077434
   PubMed Web of Science ®Google Scholar
• FavaAPirritanoDPlastinoMThe effect of lipoic acid therapy on cognitive functioning in patients with Alzheimer’s diseaseJ Neurodegener Dis2013201345425326316990
   PubMedGoogle Scholar
• WitteAVKertiLMarguliesDSFloelAEffects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adultsJ Neurosci201434237862787024899709
   PubMed Web of Science ®Google Scholar
• VenigallaMSonegoSGyengesiESharmanMJMünchGNovel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer’s diseaseNeurochem Int201595637426529297
   PubMed Web of Science ®Google Scholar
• PohankaMVaccination to Alzheimer Disease. Is it a promising tool or a blind way?Curr Med Chem201623141432144127087245
   PubMed Web of Science ®Google Scholar
• ZotovaEBharambeVCheaveauMInflammatory components in human Alzheimer’s disease and after active amyloid-β42 immunizationBrain201313692677269623943781
   PubMed Web of Science ®Google Scholar
• MengQHLouFLHouWXLiuMGuoHZhangXMAcetylpuerarin reduces inflammation and improves memory function in a rat model of Alzheimer’s disease induced by Abeta1-42Pharmazie2013681190490824380241
   PubMed Web of Science ®Google Scholar
• JiaoSSYaoXQLiuYHEdaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficitsProc Natl Acad Sci USA2015112165225523025847999
   PubMed Web of Science ®Google Scholar
• WuLYBaoXQPangHYSunHZhangDFLZ attenuates learning and memory deficits via suppressing neuroinflammation induced by LPS in miceJ Asian Nat Prod Res201517330631725621771
   PubMed Web of Science ®Google Scholar
• CasamentiFGrossiCRigacciSPantanoDLuccariniIStefaniMOleuropeinaglycone: a possible drug against degenerative conditions. In vivo evidence of its effectiveness against Alzheimer’s diseaseJ Alzheimers Dis201545367968825649656
   PubMed Web of Science ®Google Scholar
• WangSYangHYuLOridonin attenuates Aβ1-42-induced neuroinflammation and inhibits NF-κB pathwayPLoS One201498e10474525121593
   PubMed Web of Science ®Google Scholar
• SongYCuiTXieNZhangXQianZLiuJProtocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic miceInt Immunopharmacol201420127628124667368
   PubMed Web of Science ®Google Scholar
• XuPXWangSWYuXLRutin improves spatial memory in Alzheimer’s disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammationBehav Brain Res201426417318024512768
   PubMed Web of Science ®Google Scholar
• CantarellaGDi BenedettoGPuzzoDNeutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer’s diseaseBrain2015138120321625472798
   PubMed Web of Science ®Google Scholar
• CountsSERayBMufsonEJPerezSEHeBLahiriDKIntravenous immunoglobulin (IVIG) treatment exerts antioxidant and neuropreservatory effects in preclinical models of Alzheimer’s diseaseJ Clin Immunol2014341 SupplS80S8524760109
   PubMed Web of Science ®Google Scholar
• XingXNZhangWGShaSAmyloid β 3-10 DNA vaccination suggests a potential new treatment for Alzheimer’s disease in BALB/c miceChin Med J (Engl)2011124172636264122040416
   PubMed Web of Science ®Google Scholar